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Abstract
Background: Research into gene expression enables scientists to decipher the complex regulatory networks that
control fundamental biological processes. Quantitative real-time PCR (qPCR) is a powerful and ubiquitous method
for interrogation of gene expression. Accurate quantification is essential for correct interpretation of qPCR data.
However, conventional relative and absolute quantification methodologies often give erroneous results or are
laborious to perform.
To overcome these failings, we developed an accurate, simple to use, universal calibrator, AccuCal.
Results: Herein, we show that AccuCal quantification can be used with either dye- or probe-based detection
methods and is accurate over a dynamic range of ≥105 copies, for amplicons up to 500 base pairs (bp). By
providing absolute quantification of all genes of interest, AccuCal exposes, and circumvents, the well-known biases
of qPCR, thus allowing objective experimental conclusions to be drawn.
Conclusion: We propose that AccuCal supersedes the traditional quantification methods of PCR.
Keywords: qPCR, Absolute quantification, Universal calibrator, Gene expression
Background
Significant differences in gene expression between
tissues, disease states or treatment groups steer the dir-
ection of much research. It is imperative therefore, that
mRNA quantification methods are standardized, accur-
ate and unbiased. Due to its sensitivity, qPCR has be-
come the standard method for measuring levels of gene
expression. Quantification of PCR may be relative or
absolute, and traditionally has been performed using
non-specific intercalating dyes or gene-specific fluores-
cent probes. These methods, although widely used, are
known to have many fundamental problems, despite
considerable efforts over the last 20 years to overcome
these.
Relative quantification using intercalating dyes is the
most common method used. It is simple and cheap to
perform, but relies on the use of one or more reference
genes, against which the mRNA concentrations of the
genes of interest (GOIs) are normalized [1]. The optimal
number and choice of reference genes is determined em-
pirically, but various useful computational methods help
researchers in this regard [2, 3]. A suitable reference
gene must be stably expressed between the experimental
groups, have similar amplification efficiency and abun-
dance to the GOIs. In reality this is rare, and reference
genes often introduce bias into an experiment, leading
to erroneous interpretation of results [4, 5].
Absolute quantification is performed by constructing a
standard curve for each GOI and plotting the quantifica-
tion cycle (Cq) values against log[quantity] of a dilution
series of known GOI amount. These standards, compris-
ing purified PCR product, plasmid DNA constructs or
synthetic oligonucleotides spanning the PCR amplicon,
are amplified, as are any experimental errors. This is
important as the standard curve provides both the effi-
ciency of the amplification primers and the amount of
GOI in the unknown samples. Ideally, a new standard
curve is generated each time a sample is quantified, but
in practice, due to the complexity of the method, many
researchers generate a standard curve once and use it re-
peatedly to quantify samples over a period of time. This
produces inaccurate results as the efficiency of
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amplification may vary across samples, with time, or be-
tween the target used to generate the standard curve
and the ‘real’ target within a complex sample [6].
The Minimum Information for publication of Quanti-
tative real-time PCR Experiments (MIQE) guidelines [7]
were introduced to facilitate standardization of the ex-
perimental and reporting practices in qPCR, to enable
more reliable and unequivocal interpretation of qPCR
results. These have helped enormously, but the funda-
mental problems associated with identifying suitable ref-
erence genes for an experiment, or having to generate
standard curves for each GOI, are still present and can
result in misinterpreted data.
AccuCal™, a universal Accurate Calibrator, was devel-




To address the long-standing problems of traditional
PCR quantification methods [8], a methodological solu-
tion must integrate easily into each qPCR run, provide
accurate results and ideally be universally applicable.
The method relies on AccuCal-D, a double stranded
DNA calibrator for use with intercalating dyes, or
AccuCal-P, a single stranded, fluorescently labelled
calibrator for probe-based qPCR assays. An initial
optimization is required, but following this, the AccuCal
method involves three simple steps (Fig. 1a and detailed
in the Methods). RealCount™ software was developed to
automate the computational steps.
To determine the AccuCal-D range to use, the initial
optimization was performed under the same reaction
conditions as for DNA amplifications. In the example
shown, a range of 0–140 ng, was optimal, as this
spanned the exponential portion of the amplification
curves, where the amount of amplified target is directly
proportional to the input amount [9, 10], and gave a lin-
ear calibration curve with R2 value of 0.9987 (Fig. 1b, c
and Additional file 1). This determination only needs to
be performed once, provided reaction conditions of all
subsequent PCRs remain constant.
To show the quantification accuracy of AccuCal-D, we
amplified serial ten-fold dilutions of known quantities of
a 92 bp amplicon from lambda DNA, from 4.5 × 106 –
4.5 × 101 copies, in quadruplicate alongside AccuCal-D,
at the predetermined amounts, and plotted the calibra-
tion curve (Fig. 1b-d). The efficiency of each amplifica-
tion reaction was then determined by RealCount using
known algorithms [10]. Finally, using the efficiency
values and calibration curve, the mean amount of input
DNA, and standard error of the mean, was calculated
for all cycles during the exponential phase of each amp-
lification curve using RealCount (Fig. 1e). A regression
analysis between the determined values and the theoret-
ical amount seeded into the PCR yielded an R2 of 0.9977
(Fig. 1f ) demonstrating the utility of the AccuCal-D
method and its accuracy in absolute quantification of
real-time qPCR.
AccuCal-D relies on an intercalating dye to generate
fluorescence, but the dye:AccuCal-D fluorescence ratio
is unknown. To understand this relationship, we devel-
oped a probe-based version of AccuCal, AccuCal-P. A
92 bp amplicon from a range of concentrations of
lambda DNA was amplified and detected using either a
FAM-labelled hydrolysis probe or EvaGreen intercalating
dye. Both AccuCal-D and FAM-labelled AccuCal-P were
included on the PCR plate and were used independently
to quantify the lambda DNA detected by both markers.
The quantification using either AccuCal-D or AccuCal-
P, for both sets of PCR amplifications, yielded indistin-
guishable results for each dilution with no significant
differences between the slopes when theoretical number
of copies is plotted against determined number of copies
(slopes = 0.9601, 0.9653, 0.9623 and 0.9701, R2 = 1 for each;
Fig. 2a and Additional file 1). AccuCal-P and the hydrolysis
probe are labelled with one FAM moiety per DNA mol-
ecule, and report the same fluorescence per DNA molecule
as the EvaGreen dye does under these qPCR conditions.
To determine the range of amplicon sizes for which
AccuCal-D quantification can be used, we also ampli-
fied lambda amplicons of 501 bp. Amplicons of 92 bp
to 501 bp covers the spectrum of amplicon sizes that
are typically amplified by qPCR. Again, AccuCal-P
and a FAM-labelled template-specific hydrolysis probe
were used as a comparator for AccuCal-D and inter-
calating dye. The results show that the quantification
is similar for both amplicon sizes whether this is cal-
culated using AccuCal-D or AccuCal-P, with neither
slope differing significantly from 1 (Fig. 2b). This sug-
gests that the dye and probe fluorescence remains
constant over this range of amplicon sizes and there-
fore AccuCal can be reliably used to quantify any
amplicon within this range.
To evaluate the performance of AccuCal-D in a variety
of dye-based mastermixes on a number of real-time
qPCR platforms, eight independent research groups
were provided with AccuCal-D and reagents for lambda
amplification (92 bp amplicon). Each laboratory ampli-
fied their GOIs and known input amounts of lambda
under a range of conditions typical for those laborator-
ies. The results show that AccuCal-D provides an accur-
ate, absolute quantification of known concentrations of
lambda DNA in these varied and independent tests
(Fig. 2c). When compared collectively across all plat-
forms, the mean determined quantification correlates
perfectly with the theoretical number of copies in each
PCR (Fig. 2c, slope = 1).
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When integrated onto each qPCR run under the same
conditions as the GOI(s), AccuCal provides robust abso-
lute quantification over a range of input amounts and
amplicon sizes, in dye- or probe-based assays.
AccuCal provides confidence in relative quantification
analysis
Relative quantification e.g. ΔΔCq [11] and Pfaffl [12]
analyses, has traditionally been the simplest and most
commonly used method of PCR quantification.
Although AccuCal provides absolute quantification, it
can be applied relatively.
To compare AccuCal-D with ΔΔCq and Pfaffl ana-
lyses, we assessed levels of CD40 and Interleukin 7 re-
ceptor alpha chain (IL7R) variants. Activation of human
peripheral blood mononuclear cells (PBMCs) reveals a
repertoire of splice variants of these genes which reflect
a predisposition to multiple sclerosis [13, 14]. We con-
ducted experiments to measure levels of CD40 and IL7R
in human PBMCs via qPCR following 24 h activation
with varying amounts of phorbol myristate acetate
Fig. 1 Quantification of PCR amplified nucleic acid using AccuCal calibrator. a The workflow associated with using AccuCal to quantify input
nucleic acid amount in each PCR, b AccuCal calibrator was diluted so that 0, 40, 60, 80, 120, 140 and 200 ng in Sso Fast EvaGreen Supermix were
added to respective wells of a PCR plate and subjected to 40 amplification cycles. c The fluorescence intensity of each AccuCal calibrator (after
subtraction of mean 0 ng AccuCal fluorescence) was plotted against the amount (pmols) and a linear regression line fitted to generate the
calibration curve. d Ten-fold dilutions of lambda DNA, ranging from 4.5 × 106 – 4.5 × 101 copies/PCR, were amplified in quadruplicate in Sso Fast
EvaGreen Supermix on the same plate as the AccuCal calibrators. e The calibration curve was used, alongside the calculated efficiency of each
amplification reaction and the cycle numbers between the take-off point (Cq) and second derivative maxima for each amplification reaction, to
quantify the mean starting amount of DNA in each PCR. The standard error of the mean is also presented. f The theoretical and determined
number of copies/PCR, plus SEM, were plotted against each other and a regression line drawn to demonstrate the agreement between the
two values
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(PMA) and ionomycin (PMA/I). Absolute quantification of
the qPCR was performed using AccuCal-D and RealCount
(Fig. 3a and Additional file 1). Relative quantification was
assessed by expressing the absolute AccuCal-D values rela-
tive to the no PMA/ionomycin control, or by traditional
ΔΔCq or Pfaffl analyses using glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) as a reference gene and the
unstimulated cells as a control (Fig. 3b). For Pfaffl analysis,
the efficiencies calculated by RealCount were used.
Both the absolute and relative analyses showed the ex-
pression of IL7R was 3–10 fold lower in stimulated cells
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Fig. 2 Quantification using both AccuCal-D and AccuCal-P. a Five, ten-fold dilutions of a known quantity of lambda DNA, ranging from
4.5 × 105 to 4.5 × 101, were amplified twice in quadruplicate and detected using either EvaGreen, the intercalating dye in Sso Fast
mastermix, or a FAM-labelled hydrolysis probe specific to the target amplicon. In both cases, AccuCal-D and AccuCal-P calibrators were
included on the same plate and used to independently quantify the starting amount of input DNA in each PCR. The theoretical amount
versus the calculated amount, determined by either AccuCal-D or AccuCal-P, using the EvaGreen dye (EG) or the hydrolysis probe (P), was plotted and
the linear regression of each is shown in the graph on the right. b Five, ten-fold dilutions of a known quantity of lambda DNA in quadruplicate were
amplified in Sso Fast mastermix using primers to give a 501 bp amplicon. AccuCal-D and AccuCal-P calibrators were included on the same plate and
were used to independently quantify the starting amount of lambda DNA in each PCR. The theoretical amount versus the calculated
amount, determined by either AccuCal-D or AccuCal-P, for the 501 bp amplicon, was plotted and the linear regression of each is shown
in the graph on the right. c Five, ten-fold dilutions (3 one-hundred fold dilutions on the Eco) of a known quantity of lambda DNA were
amplified in various mastermixes (see Methods) on the different qPCR platforms indicated over 2–10 PCR runs. The theoretical amount
versus the mean calculated amount, determined by AccuCal-D, across all platforms was plotted and the linear regression is shown in the
graph on the right. The mean number of calculated copies/PCR and SEM are shown in each case
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Fig. 3 Quantification of CD40, IL7R and GAPDH in PBMCs stimulated with 0–1x PMA/ionomycin. a Absolute quantification of CD40, IL7R and GAPDH in
PBMCs stimulated with 0, 0.25x, 0.5x and 1x PMA/ionomycin (20 ng ml−1 PMA, 500 ng ml−1 ionomycin; PMA/I) by RealCount software following qPCR
using AccuCal-D calibrators. b Relative expression levels of CD40 and IL7R in PBMCs stimulated with 0, 0.25x, 0.5x and 1x PMA/ionomycin (20 ng ml−1
PMA, 500 ng ml−1 ionomycin). The hatched bars are relative expression levels determined by ΔΔCq using GAPDH as the reference gene
and no PMA/ionomycin as the control sample, solid bars are relative expression levels determined by Pfaffl analysis, using GAPDH as
reference gene, unstimulated cells as controls and individual efficiency values calculated by RealCount software, and the checkered bars
are quantified by RealCount software following inclusion of AccuCal-D in the same PCR run, and expressed relative to the no PMA/ionomycin control.
c Representative overlay graphs from flow cytometry showing relative measurement of CD40 and IL7R in the same population of PBMCs stimulated
with 0 (red), 0.25x (blue), 0.5x (green) and 1x PMA/ionomycin (20 ng ml−1 PMA, 500 ng ml−1 ionomycin; orange) as in (a). **** p < 0.0001 relative to
respective no PMA/ionomycin control, n = 4
Boulter et al. BMC Biotechnology  (2016) 16:27 Page 5 of 14
cells whereas any differences in the levels of CD40 were
of no great significance. In this experiment, the inter-
pretation of the qPCR data from the ΔΔCq and Pfaffl
analyses was the same as that provided by AccuCal-D
(Fig. 3b). The assumption for ΔΔCq and Pfaffl analyses
is that the level of GAPDH reference gene remains con-
stant between treatments. Importantly, absolute quantifi-
cation using AccuCal-D indicated that this was indeed
the case (Fig. 3a). The results of the qPCR analyses were
supported by flow cytometry, showing no difference in
the level of CD40 expression and a 3–5.5 fold decrease
in expression of IL7R in the treatment group compared
to the untreated cells (Fig. 3c).
Importantly, AccuCal-D and RealCount analysis pro-
vides data regarding the expression levels of all genes,
including the reference gene, between treatments/groups
(Fig. 3a), and the individual efficiencies for each amplifi-
cation reaction, which are not available using ΔΔCq and
Pfaffl analyses.
AccuCal supersedes traditional quantification analyses
Prostate epithelium-specific phosphatase and tensin
homolog knockout (pePTENKO) induces prostate path-
ology [15] and modifies prostate specific androgen receptor
(AR) expression in mice as determined by immunohisto-
chemistry (Fig. 4a and Additional file 1) or Western blot
(Fig. 4b). The Western analysis showed that levels of
β-actin (ACTB) protein were constant and were used
to determine relative protein expression levels. The AR
protein content was significantly greater (p = 0.008) in
prostate tissue from pePTENKO mice compared to
wild-type (WT; Fig. 4b).
To determine whether these complex assays could be
replaced by mRNA analysis using qPCR, we PCR ampli-
fied Ar and Actb from prostate RNA extracted from WT
and pePTENKO mice. Initially, relative quantification
was undertaken by traditional ΔΔCq and Pfaffl analyses
with Actb as the reference gene and WT as the control.
Actb was chosen as the protein was stably expressed
between groups (Fig. 4b). The ΔΔCq and Pfaffl analyses
indicated that there was no significant change in Ar ex-
pression levels in pePTENKO mice compared to WT
(1.250 and 1.286 fold increase, respectively; Fig. 4c). It is
known that protein and mRNA levels do not necessarily
correlate [16, 17], which may explain this result. Alterna-
tively, the relative qPCR analysis may be incorrect.
Examination of the amplification plots suggested a
greater expression of Ar, as well as Actb, in the prostate
of pePTENKO mice (Fig. 4d).
To resolve this issue, we used absolute quantification
via AccuCal-D, or standard curves, to determine the
levels of Ar and Actb in pePTENKO and WT mice. The
results demonstrated that expression levels of each gene
had similar absolute quantifications by both methods
(Fig. 4e) and were significantly higher in prostate from
pePTENKO mice than WT mice for both standard curve
and AccuCal-D (Ar, p < 0.0001 and p < 0.0001; Actb,
p = 0.0049 and p = 0.0043, respectively; Fig. 4f). When
expressed in a relative manner, Ar expression in peP-
TENKO mice was 3.806 fold higher than WT mice by
standard curve quantification and 3.697 fold higher by
AccuCal-D quantification. Both of these were significantly
different from the ΔΔCq and Pfaffl analyses using Actb as
a reference gene (p < 0.0001; Fig. 4h), but were in accord
with the Western blot results. In this example, the ΔΔCq
and Pfaffl analyses were not accurate because the refer-
ence gene used changed similarly to the GOI between the
phenotypes (Fig. 4f).
Additionally, we quantified, with AccuCal-D, a number
of other possible reference genes to use for normalization.
There was no significant difference between the expression
of ribosomal protein L19 (Rpl19) and hydroxymethylbilane
synthase (Hmbs) between WT and pePTENKO, but the
remaining reference genes were all expressed significantly
more abundantly in the prostates of pePTENKO mice than
WT mice, highlighting the difficulty in finding a suitable
reference gene in some experiments (Fig. 4g). We then
repeated the ΔΔCq and Pfaffl analyses using the least
variable reference gene, Hmbs, and the results (4.294 and
3.603 fold increases, respectively) were very similar to
those obtained using AccuCal-D or standard curve
quantification, and significantly different from the ΔΔCq
and Pfaffl analyses undertaken using Actb as a reference
gene (p < 0.0001 in both cases; Fig. 4h).
In the exemplar described, AccuCal-D provided an al-
ternative quantification method, independent of refer-
ence genes, where these are difficult to find (Fig. 4h).
Importantly, we have also shown that absolute quantifi-
cation by standard curve perfectly matched AccuCal-D
analysis (Fig. 4e, f ). This demonstrated that the protein
and gene expression levels of AR/Ar correlated, allowing
the use of mRNA analysis by qPCR as a faithful reporter
assay. Notably, AccuCal provided this information much
more simply than the standard curve method, and a sin-
gle calibration curve could be used to quantify all genes
investigated concurrently.
Discussion
Traditional relative and absolute methods of qPCR have
many, well-accepted flaws and errors [7]. The MIQE
guidelines sought to minimize these, but the problems
associated with reference genes, and the need to con-
struct a standard curve for each GOI, remain. To over-
come these limitations, an accurate, universal calibrator
(AccuCal) was developed.
AccuCal can be included in any dye- (AccuCal-D) or
probe-based (AccuCal-P) qPCR experiment. The tech-
nology works robustly for amplicons up to 500 bp in
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Fig. 4 (See legend on next page.)
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length over a dynamic range of ≥105 copies, and in a
range of mastermixes, real-time PCR platforms and la-
boratories. A range of AccuCal concentrations is in-
cluded in each qPCR run and used to generate a
calibration curve to quantify the amount of any GOI.
Significantly, AccuCal fluoresces proportionally to the
amount of DNA in the well but is not PCR amplified,
thus minimizing errors in quantification (e.g. due to er-
rors in pipetting or spectrophotometric estimation of in-
put nucleic acid concentrations) [18]. Customized
software, RealCount, automates the quantification calcu-
lations, streamlining data analysis.
Essential to current relative quantification methods are
reference genes and the assumption that these do not
change between treatments or groups. Many studies
have shown that commonly used reference genes vary
with experimental conditions and between tissues, while
some, such as Actb and GAPDH, have pseudogenes [19]
which may produce specific amplification products in an
mRNA-independent fashion [20]. The MIQE guidelines
recommend the use of multiple reference genes to pro-
vide a more accurate normalization [7]. However, in
some experiments, this can be very difficult to achieve,
as exemplified in our mouse prostate example. AccuCal
provides quantification independently of reference genes
and is therefore a much simpler method to use and is
devoid of these problems.
Reference genes are also often included in gene ex-
pression studies to account for differences in reverse
transcription (RT) efficiencies between experiments.
These have been shown to often result in relative gene
differences of 2–5 fold or more [21, 22] depending upon
the RNA concentration and integrity, the RT enzyme
used, the priming strategy employed, the sample used
and reaction conditions [23]. RT differences have also
been shown to be gene dependent which questions the
validity of using any gene as a normalizer for RT and
PCR and may mask results, leading to erroneous inter-
pretation of data. Methods that help resolve differences
in RT efficiency are required, but in their absence, differ-
ences in gene expression <5 fold need to be construed
cautiously.
AccuCal allows the researcher to objectively see any
differences in absolute gene expression of all genes. This
potentially unmasks differences in RT efficiency and
provides valuable information regarding reference gene
expression, giving confidence, or otherwise, to the re-
searcher about reference gene choice or RT differences.
In cases where reference genes are stable, the results
generated by AccuCal and traditional relative methods
agree, but when the reference gene expression is not
stable between samples, relative quantification leads to
incorrect interpretation, whereas AccuCal provides an
unbiased, interpretable result.
The current gold standard in qPCR is absolute quanti-
fication using standard curves. Comparison of the quan-
tification of Ar and Actb by AccuCal or standard curves
demonstrated that the results were completely inter-
changeable. The major impediments of standard curve
analysis include i) the requirement to obtain standards
for each GOI; ii) the need to generate a separate stand-
ard curve for each GOI for each qPCR run; iii) the effi-
ciency obtained from the standard curve may not be
representative of the samples used in experiments; and
iv) cost and time involved [24]. Thus, standard curves
are laborious, whereas a single AccuCal calibration
curve, and analysis by RealCount, can be used to quan-
tify all GOIs on the same PCR plate, thereby making the
AccuCal method simpler, cheaper and quicker to
perform.
PCR efficiencies are rarely perfect and they may vary
between samples even under identical reaction condi-
tions, e.g. due to slight differences in the quantity of in-
hibitors present [25]. A small change in efficiency from
2.00 to 1.97 over 30 cycles equates to a 57 % difference
in input DNA calculation, while a change from 2.00 to
1.90 over the same range makes 365 % difference (calcu-
lated using ((2n/En)-1) × 100, where E is efficiency and n
(See figure on previous page.)
Fig. 4 Quantification of protein and mRNA levels of androgen receptor (AR, Ar) in mouse anterior prostate. a Representative immunohistochemistry
showing AR protein expression (brown staining) and differential pathology in prostate of WT and pePTENKO mice. b Quantification of AR protein by
Western blot in anterior prostates of WT (n = 2) and pePTENKO (n = 4) mice, using β-actin (ACTB) as a loading control to determine relative protein
levels. c Relative quantification of Ar by ΔΔCq and Pfaffl analyses using Actb as the reference gene and WT as the control. d qPCR of Ar and Actb in WT
(blue curves, n = 7 in duplicate) and pePTENKO (red curves, n = 5 in duplicate) mice. e Comparison of theoretical versus determined quantification of
serial dilutions of plasmids containing Ar or Actb amplicons, by either traditional standard curves (blue diamonds and line) or use of
AccuCal and RealCount (red squares and line). f Absolute mRNA copy number quantification of Ar and Actb reference gene in the anterior
prostate of WT (n = 7) and pePTENKO (n = 5) mice as determined by RT-qPCR with AccuCal calibrators and RealCount software (AC) or
standard curves (Std). g Absolute quantification of a number of reference genes using AccuCal and RealCount for both WT (n = 7) and
pePTENKO (n = 5) mice. h Comparison of relative quantification methodologies for Ar. ΔΔCq and Pfaffl analyses used either Actb or Hmbs
as the reference gene and WT as the control, and AccuCal (AC) and standard curve (Std) absolute values were expressed in a relative
manner to WT as the control. All graphed data is displayed as mean ± SEM. **** p <0.0001, ** p = 0.001–0.01, * p = 0.01–0.05 by independent two
sample t-test between expression of androgen receptor or β-actin mRNA or protein in pePTENKO mice compared to WT mice, or between relative
expression methods compared with ΔΔCq and Pfaffl performed using Actb as reference gene
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is cycle number). Methods that assume perfect efficiency
(i.e. 2) such as ΔΔCq analysis [11] are thus flawed [26].
The ‘Pfaffl’ method [12] of analysis is more accurate as it
uses the efficiencies of the individual primers. However,
these efficiencies are onerous to obtain, requiring a
standard curve to be generated for each GOI. Over the
last 10–15 years, many researchers have made progress
in developing algorithms for single sample kinetic PCR
analysis [10, 27–32]. We have selected one of these [10]
for incorporation into RealCount software to automate
individual efficiency calculations and therefore improve
upon the accuracy of the quantification over traditional
methods which use an averaged or assumed efficiency.
Conclusion
In summary, we have shown that AccuCal provides
an easy alternative to traditional qPCR quantification
methods. AccuCal removes the bias of troublesome
reference genes and provides the accuracy of standard
curves without the hassle. It can be used in every
qPCR experiment to standardize dye- or probe-based
assays. RealCount software automates the quantifica-
tion process. The simplicity of AccuCal, its broad
utility and the ability to quantify all GOIs on a PCR
plate, make AccuCal a truly universal calibrator.
Methods
AccuCal calibrators
AccuCal-D (Accugen) is a proprietary 90 bp, 44 % GC
content, double-stranded DNA calibrator that can be
used to provide an accurate, absolute quantification in
qPCR using intercalating dyes. AccuCal-P (Accugen)
comprises a range of proprietary 21 bp, 62 % GC con-
tent, single-stranded DNA calibrators that are labelled
on the 5′ end by conventional means with any single
fluorophore molecule per moiety and can be used for
absolute quantification in probe-based qPCRs. In these
experiments, AccuCal-P was labelled with FAM, but any
fluorophore that matches the excitation and emission
spectra of the fluorophore on the detection probe for
the gene(s) of interest (GOIs) can be used. Multiple
Accual-P calibrators labelled with different fluorophores
can also be added simultaneously to the same well to en-
able multiplexing if desired. The methodology for using
AccuCal-D and AccuCal-P, collectively referred to as
AccuCal, is the same.
Generating an AccuCal calibration curve
We performed an initial calibration run on each qPCR
platform using a range of dilutions of AccuCal-D or
AccuCal-P as appropriate, from 0 ng up to 500 ng per
well to determine the optimal range of AccuCal to use.
AccuCal was diluted in nuclease-free water (Sigma) and
made up in the same PCR master mix, and to the same
volume, as used during PCR, omitting primers and tem-
plate. The calibrator, although not amplified, was sub-
jected to PCR cycling under the conditions used for
amplifying the GOIs, and the fluorescence data acquired
at the end of each cycle as normal. We then determined
the optimal range of AccuCal to use by importing the
raw fluorescence data into RealCount software (Accu-
gen), subtracting the background fluorescence reading,
which is provided by the 0 ng AccuCal (comprising
water and master mix only), and choosing those concen-
trations that produce a linear calibration curve within
the detection limits of the platform in question. Typic-
ally, the ideal range is between 0 ng and 200 ng and
should span the detectable exponential portion of the
amplification curve between the take-off point and the
second derivative maxima. At least six concentrations of
AccuCal spanning the optimal range and including a
0 ng control is then used on every subsequent PCR,
preferably in duplicate, to produce a calibration curve.
Quantification using AccuCal and RealCount
Following qPCR amplification of the GOIs, and in-
clusion of the pre-determined range of AccuCal cali-
brators, the raw fluorescence data was imported into
RealCount software and the calibration curve auto-
matically plotted. The software calculates the effi-
ciency of individual qPCR amplifications over the
exponential portion of the amplification curve using
a published algorithm [10]. From the calibration
curve, we determined the pmols of DNA over the
exponential portion of each amplification curve and
calculated the mean initial input DNA using the
equation pmz = pm/En, where pmz is pmols at time
zero, E is efficiency and n is cycle number. The pmz
is converted into copies/PCR using pmz × 6.022 ×
1023 × 10−12. The software provides a mean, stand-
ard deviation and standard error of the mean output
for the quantification of the initial input amount of
the gene(s) of interest in the qPCR reaction during
the entire detectable exponential phase.
Tissue culture, animal handling, mouse models and tissue
harvesting
We seeded 105 human peripheral blood mononuclear cells
(PBMCs) in culture medium (X-Vivo 15 (Lonza) contain-
ing 10 mM HEPES (Life Technologies), 2 mM L-glutam-
ine (Life Technologies) with 50 μM 2-mercaptoethanol
(Amresco)) per well in a 96-well round bottom plate in
quadruplicate and incubated at 37 °C with 5 % CO2 for
24 h with either culture medium alone, 0.25x phorbol
myristate acetate (PMA)/ionomycin (5 ng mL-1 PMA
(Sigma) and 125 ng mL-1 ionomycin (Sigma)), 0.5x PMA/
ionomycin (10 ng mL-1 PMA, 250 ng mL-1 ionomycin) or
1x PMA/ionomycin (20 ng mL-1 PMA, 500 ng mL-1
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ionomycin). Cells were washed in PBS and either har-
vested directly for flow cytometry or the cell pellet was
suspended in 100 μl Cells-to-Signal lysis buffer (Life Tech-
nologies) for RNA isolation.
Mice were housed on a 12 h:12 h cycle of light and
dark at 19–22 °C. Mice were fed food and water ad
libitum. All experiments were approved by the Sydney
South West Area Health Service Animal Welfare
Committee within National Health and Medical
Research Council guidelines for animal experimenta-
tion. The prostate epithelium specific phosphatase
and tensin homolog knockout (pePTENKO; FVB/N
background) mice were generated by crossing
Ptenloxp/loxp mice [33] to the probasin Cre (Tg(Pbsn-
cre)) transgenic line [34]. In Tg(Pbsn-cre) mice the
Cre is controlled by the prostate epithelial cell-
specific, modified probasin gene promoter. Cre
negative littermates were used as wild-type controls
(denoted as WT).
We genotyped experimental mice using genomic DNA
from mouse tails amplified by PCR. The primer pair se-
quences used for genotyping mice were as follows: Cre for-
ward 5′-CTGACCGTACACCAAAATTT GCCTG-3′ and
reverse 5′-GATAATCGCGAACATCTTCAGGTTC-3′
[35], PTEN forward 5′- TCCCAGAG TTCATACCA
GGA -3′ and PTEN reverse-1 5′- GCAATGGCCAG-
TACTAGTGAAC -3, PTEN reverse-2 5′- AATCTG
TGCATGAAGGGAAC -3′ [36].
Anterior prostate was collected from WT and peP-
TENKO male mice at average age of 20 weeks. Mice
were anesthetized with ketamine/xylazine and eutha-
nized by cardiac exsanguination. Anterior prostate was
dissected free of surrounding fat, snap frozen in liquid
nitrogen and stored at −80 °C for further RNA or pro-
tein extraction.
Ethics statement
Human PBMCs were collected from healthy donors
with informed written consent following approval by
the Western Sydney Local Health District (WSLHD)
Human Research Ethics Committee under permit
number HREC 2002/9/3.6(1425). The consent forms
are vetted and approved by the Scientific Advisory
Committee and the WSLHD Human Research Ethics
Committee, and are then securely stored as a hard
copy for 15 years under current NH&MRC
requirements.
All animal experiments were approved by the Sydney
South West Area Health Service Animal Welfare Com-
mittee within National Health and Medical Research
Council guidelines for animal experimentation (permit
number 2009/009B). All efforts were made to minimize
suffering.
Isolation of RNA and cDNA synthesis
Following stimulation with varying concentrations of
PMA and ionomycin, we isolated RNA from 100,000
human PBMCs using the RNeasy mini kit (Qiagen) as
per the manufacturer’s instructions. RNA was reverse
transcribed using qScript cDNA supermix (Quanta Bio-
sciences) according to the manufacturer’s instructions.
We checked the concentration, purity and integrity of
RNA using a Bioanalyzer (Illumina).
RNA was extracted from approximately 30 mg of an-
terior prostate from WT and pePTENKO mice using the
RNeasy Mini kit (Qiagen) according to the manufac-
turer’s instructions. The concentration and purity of
total RNA was measured using the Nanophotometer
(Implen) by measuring absorbance at 260, 280 and
230 nm. RNA integrity was assessed by gel electrophor-
esis. To remove residual genomic DNA contamination,
2 μg of RNA was treated with ribonuclease-free DNase I
(0.5 U μg-1 RNA; Invitrogen). 1 μg of RNA was reverse
transcribed to produce cDNA utilizing the Superscript
III first strand synthesis SuperMix for qRT-PCR kit
(Invitrogen) according to the manufacturer’s protocol.
Real-time PCR
We undertook amplification of a ten-fold dilution series
of lambda DNA (Hind III digest, New England Biolabs),
ranging from 4.5 × 106 – 4.5 × 101 and quantified using
a NanoDrop 1000 spectrophotometer (Thermo Scien-
tific), in Sso Fast EvaGreen Supermix (Bio-Rad) as per
manufacturer’s instructions, in a 20 μl final volume. The
expected amplicon size is 92 bp and the primer se-
quences are listed in Table 1. PCR cycling was performed
at 95 °C, 2 min, followed by 40 cycles of 95 °C, 5 s; 60 °C,
30 s on a RotorGene-6000 (Qiagen), with the fluorescence
acquired at the end of each cycle and the gain set to 7 in
the green channel. A melt curve performed at the end of
the amplification was undertaken to confirm that there is
only a single product amplified in each reaction.
Serial dilutions of lambda DNA were also amplified
as above in either Sso Fast EvaGreen Supermix or in
Go Taq hot start colorless mastermix (Promega), the
latter being detected with an hydrolysis probe specific
to the amplicon and having the sequence 5′ 56-FAM/
aacactcaggcacgcggtctg/3IABkFQ 3′ (Integrated DNA
Technologies). Suitable amounts of both AccuCal-D
and AccuCal-P (between 0 ng and 200 ng for both)
were run alongside the PCRs and all PCRs were
quantified using the calibration curves generated by
both the calibrators independently.
Lambda amplicons sized 92 bp and 501 bp, which
span the typical range for real-time qPCR, were ampli-
fied using the primers listed in Table 1 and the same
cycling conditions as above with the exception of an an-
nealing/extension time of 1 min for the larger product.
Boulter et al. BMC Biotechnology  (2016) 16:27 Page 10 of 14
Researchers in eight independent labs tested the uni-
versality and accuracy of AccuCal-D on various qPCR
machines and in different mastermixes. The qPCR plat-
form/mastermix combinations tested were RotorGene
6000 (Qiagen)/SensiMix™ SYBR® Hi-Rox (Bioline),
Mastercycler® ep series (Eppendorf )/GoTaq® qPCR
mastermix (Promega), CFX™96 (Biorad)/Sso Advanced™
SYBR® green (Bio-Rad), ViiA™7 #1 (Life Technologies)/
GoTaq® qPCR mastermix (Promega), ViiA™7 (#2)/Fast
SYBR® green (Life Technologies), 7900HT (Applied
Biosystems)/EXPRESS SYBR® GreenER™ qPCR supermix
universal (Life Technologies), Eco (Illumina)/Power SYBR®
green (Applied Biosystems) and qTOWER (Analytik
Jena)/Sso Fast™ EvaGreen® (Bio-Rad). In all cases, in
addition to the researchers’ own PCR samples, AccuCal-D
was included on the same PCR plate alongside a set of
ten-fold serial dilutions of lambda (4.5 × 105 – 4.5 × 101,
plus no template control) which were amplified to exam-
ine the accuracy of the AccuCal quantification on each of
these platforms and in each of these mastermixes.
For PBMC experiments, qPCR was conducted in
Power SYBR Green master mix (Life Technologies) in a
12 μl reaction volume on an Eco real time PCR machine
(Illumina) using the cDNA generated from 100,000 cells
in each reaction. AccuCal-D was included at 0 ng,
10 ng, 20 ng, 30 ng, 50 ng, 70 ng and 100 ng per plate.
The primers used to amplify CD40, interleukin 7 recep-
tor α chain (IL7R, also known as CD127) and glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) are listed in
Table 1 and the cycling conditions were 96 °C, 10 min;
5 cycles (95 °C, 30 s; 64 °C, 30 s; 72 °C, 30 s); 40 cycles
(95 °C, 30 s; 60 °C, 30 s; 72 °C, 30 s); followed by a melt
curve analysis. We analyzed the results by absolute
quantification using AccuCal and RealCount, or trad-
itional relative quantification using ΔΔCq [11] or Pfaffl
[12] analyses with GAPDH as the reference gene and no
PMA/ionomycin as the control. For Pfaffl analysis, the
amplification efficiency values generated by RealCount
were used. The absolute values were also expressed rela-
tively by calculating the absolute quantification in stimu-
lated cells/absolute quantification in cells with no PMA
and ionomycin. For relative quantification methods, the
control samples (No PMA/ionomycin in this case) al-
ways have a value of 1.
Table 1 Primers used for qPCR studies
Gene Accession number Primer sequence Annealing temperature Amplicon size
Lambda NC_001416 For: CGGCGTCAAAAAGAACTTCC 60 °C 92 bp
Rev: GCATCCTGAATGCAGCCATA
Lambda NC_001416 For: CGGCGTCAAAAAGAACTTCC 60 °C 501 bp
Rev: TGATCCCACCTCATTTTCATGT
Ar NM_013476.3 For: ACCCAAAACCCACCTTGTT 64 °C 214 bp
Rev: ACGCAGCAGATTCAAAATGT
Actb NM_007393.3 For: AGCCATGTACGTAGCCATCC 64 °C 377 bp
Rev: GGAACCGCTCGTTGCCAATA
Rpl19 NM_009078.2 For: GATCATCCGCAAGCCTGTGACT 60 °C 362 bp
Rev: GTGCTTCCTTGGTCTTAGAC
Hmbs NM_001110251.1 For: TGATGAAAGATGGGCAACTG 64 °C 160 bp
Rev: ATGTTACGGGCAGTGATTCC
Rps9 NM_029767.2 For: ATTACATCCTGGGGCCTGAAG 64 °C 210 bp
Rev: AAGGAGAACGGAGGGAGAAG
Ppia BC083076.1 For: ATCACGGCCGATGACGAGCC 64 °C 217 bp
Rev: TCTCTCCGTAGATGGACCTGC
Hprt NM_013556.2 For: GATACAGGCCAGACTTTGTTGG 64 °C 154 bp
Rev: AACTTGCGCTCATCTTAGGC
CD40 NG_007279 For: GAAACTGGTGAGTGACTGC 60 °C 341 bp
Rev: CACATTGGAGAAGAAGCC
IL7R NG_009567 For: CTGGAACATCTTTGTAAGAAACCAAG 60 °C 127 bp
Rev: TAGCTTGAATGTCATCCACCCT
GAPDH NG_007073.2 For: TCCACCACCCTGTTGCTGTA 60 °C 231 bp
Rev: ACCACAGTCCATGCCATCAC
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The expression levels of androgen receptor (Ar) and
the reference genes beta-actin (Actb), ribosomal protein
S9 (Rps9), hypoxanthine guanine phosphoribosyl trans-
ferase (Hprt), peptidylprolyl isomerase A (Ppia, also
known as cyclophilin), ribosomal protein L19 (Rpl19)
and hydroxymethylbilane synthase (Hmbs), in anterior
prostate from both WT and pePTENKO mice were
assessed by qPCR in either the CFX connect real time
PCR detection system (Bio-Rad) or RotorGene-6000
(Qiagen). The reactions were performed in duplicate
using the SensiMix™ SYBR® Hi-Rox kit (Bioline) in a
10 μl reaction volume with the cDNA reverse tran-
scribed from 20 ng total RNA per reaction, according to
manufacturer’s instructions. The primers used are listed
in Table 1 and the cycling conditions comprised 95 °C
for 10 min; 45 cycles (95 °C, 30 s; 64–67 °C, 20 s; 72 °C,
30 s); 72 °C, 2 min. AccuCal-D was included on the plate
at 0 ng, 10 ng, 20 ng, 30 ng, 40 ng and 50 ng in dupli-
cate. A melt curve analysis was performed at the end of
the reaction in order to check for primer-dimer forma-
tion and contamination. The absolute quantification re-
sults were acquired by using AccuCal-D and RealCount
and, for Ar and Actb, standard curves were also gener-
ated by amplifying serial dilutions of separate plasmids
containing the amplicons. Relative quantification was
undertaken by normalizing the Ar with either Actb or
Hmbs as the reference gene and WT as the control for
ΔΔCq analysis [11] or Pfaffl analysis [12]. The absolute
values were also expressed relatively by calculating the
absolute quantification in pePTENKO/absolute quantifi-
cation in WT.
For all qPCRs, statistical differences between the
samples and control were examined by unpaired, two-
sample, Student’s t- test. Analysis of the slopes were
also undertaken to determine differences in the quan-
tification observed between the standard curves and
AccuCal/RealCount.
Flow cytometry
The levels of CD40 and IL7R α chain on the surface of the
cells were also measured by flow cytometry. Following
stimulation, we transferred cells to flow cytometry tubes
and incubated with 2.5 μl of Peridinin-Chlorophyll-
protein conjugated antibody to CD45 (Biolegend, 304002,
HI30 clone), 2.5 μl of Allophycocyanin conjugated anti-
body to CD40 (eBioscience, 17-0409-42, Clone 5C3) and
2.5 μl Phycoerythrin conjugated antibody to IL7R α chain
(eBioscience, 12-1271-42, clone eBioRDR5) for 30 min on
ice. Cells were washed once with 3 mL chilled PBS con-
taining 0.05 % sodium azide and then suspended in 250 μl
of the same buffer and read on a FACSCanto II instru-
ment (BD Biosciences). FACSDiva fcs files were analyzed
by FloJo Software (Tree Star Inc.). In all cases, CD45+
cells were gated and these gated cells were prepared as
histograms before analysis to determine median values for
CD40 and IL7R.
Western analysis
The level of androgen receptor (AR) and beta-actin
(ACTB) protein was assessed in anterior prostate tissue
from WT and pePTENKO mice by Western blot analysis
using standard techniques. In brief, anterior prostate
tissue was lysed in ice-cold RIPA lysis buffer (50 mM
Tris, 150 mM NaCl, 0.5 % Deoxycholate, 0.1 % SDS,
1 % v/v Triton X-100, Complete Protease Inhibitor
tablet [Roche], phosphatase inhibitor tablet [PhosSTOP,
Roche], pH 7.8). We homogenized the tissue in Lysing
Matrix S tubes with metal beads (MP Biomedicals) using
the PowerLyzer (MO-BIO laboratories Inc) at 2,000 rpm
for 15 s. The lysates were incubated for 30 min at 4 °C
and then centrifuged at 13,400 g for 15 min. Supernatant
was retained and transferred to a clean tube. Protein con-
centrations were determined by Micro BCA assay (Pierce)
as per manufacturer’s instructions. Equal amounts of pro-
tein (20 μg) were subjected to electrophoresis on ready-
made NuPage 10 % Bis-Tris gels (Invitrogen) and then
transferred electrophoretically onto a 0.45 μm Hybond
ECL nitrocellulose membrane (GE Healthcare). The mem-
brane was blocked overnight at 4 °C with 5 % skim milk in
TBST (20 mM Tris, 137 mM NaCl, 0.05 % Tween-20)
and then blotted overnight at 4 °C with antibody to AR
(1:1,000 in 5 % skim milk-TBST; N-20, sc-816; Santa Cruz
Biotechnology, Inc.) or ACTB (1:1,000 in 5 % skim milk-
TBST; 4967, Cell Signaling Technology). Blots were
washed with TBST (3 × 10 min) and probed with donkey
anti-rabbit IgG horseradish-peroxidase conjugated anti-
body (1:2,000; GE Healthcare) followed by another round
of 3 × 10 min TBST washes. Bands were developed using
the ECL western blotting detection kit (GE Healthcare) as
per manufacturer’s instructions on a ChemiDox XRS
System (Bio-Rad Laboratories). The membranes were ana-
lyzed using Quantity One Software (Bio-Rad Laboratories)
and images captured on the chemiluminescence setting,
exposure times varied according to the band intensity.
The signal volumes for each band were measured with
Quantity One Software in order to quantify the amount of
protein present. Statistical differences between the sam-
ples and control were examined by unpaired, two-sample,
Student’s t- test.
Immunohistochemistry analysis
In order to determine protein distribution in tissues, we
fixed anterior prostate from WT and pePTENKO mice
in 4 % paraformaldehyde in PBS (137 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) over-
night at 4 °C and transferred to 70 % ethanol. Tissues
were blocked in paraffin and immunohistochemistry for
AR (1:100 in PBS containing 10 % Pierce Superblock
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(Thermo Fisher Scientific); N-20, sc-816; Santa Cruz
Biotechnology Inc.) was performed on 5 μm thick
dewaxed paraffin sections. Microwave-induced antigen
retrieval was done with 0.01 M citrate buffer (648 mL of
0.1 M sodium citrate, 152 mL of 0.1 M citric acid
(pH 6.0)) for 15 min. Sections were washed in PBS,
blocked for 30 min with 3 % H2O2 in methanol followed
by 1 h with Pierce Superblock containing 0.5 % bovine
serum albumin and incubated 1 h at room temperature
with primary antibodies, followed by three washes in
PBS. We visualized the signal with Vectastain Elite
ABC Kit containing biotinylated anti-rabbit secondary
antibody (Vector Laboratories) followed by color de-
velopment with 3,3′-diaminobenzidine tetrahydrochloride
chromogenic substrate (Dako). Sections were counter-
stained with Harris hematoxylin and coverslipped for mi-
croscopy. Photos of immunostained prostate sections were
acquired using an EVOS FL Auto Imaging System (Life
Technologies) with a 10× objective.
Additional file
Additional file 1: Supporting data for Figs 1-4. (XLS 603 kb)
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